Finance

Lists
HOWL:NASDAQ
Werewolf Therapeutics Inc
$0.37
-1.86%
(-0.0071) 1D
Aug 11, 10:12:03 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HOWL...
Open
$0.40
High
$0.40
Low
$0.37
Mkt. cap
18.23M
Avg. vol.
842.69K
Volume
29.13K
52-wk high
$2.38
52-wk low
$0.27
EPS
-$0.73
Beta
0.29
Shares outstanding
48.60M
No. of employees
14
Open
$0.40
High
$0.40
Low
$0.37
Mkt. cap
18.23M
Avg. vol.
842.69K
Volume
29.13K
52-wk high
$2.38
52-wk low
$0.27
EPS
-$0.73
Beta
0.29
Shares outstanding
48.60M
No. of employees
14
News stories
From web sources and news partners
About Werewolf Therapeutics Inc
CEO-
Employees14
Founded2017
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitewerewolftx.com
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Buy
Reiterated
$7.00
+1,767.2%
02/17/2026
Reni Benjamin
Citizens JMP
Hold
Downgraded
-
-
12/19/2025
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$4.00
+967%
12/19/2025
Last report
Jul 31, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.14 / -$0.32
+145.16%beat
Revenue / Est. (USD)
21.00M / 0.00
+∞%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
21.00M
Cost of goods sold
10.86M
6.18M
4.50M
4.64M
Cost of revenue
10.86M
6.18M
4.50M
4.64M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.86M
3.24M
4.47M
7.82M
Operating expense
4.86M
3.24M
4.47M
7.82M
Total operating expenses
15.73M
9.42M
8.97M
12.46M
Operating income
-15.73M
-9.42M
-8.97M
8.54M
Other non operating income
-
1.84M
674.00K
64.00K
EBT including unusual items
-16.37M
-8.38M
-13.53M
3.67M
EBT excluding unusual items
-16.37M
-8.38M
-9.23M
8.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.37M
-8.38M
-13.53M
3.67M
Net profit margin
-
-
-
17.48%
Earnings per share
-0.36
-0.17
-0.28
0.14
Interest and investment income
697.00K
564.00K
433.00K
277.00K
Interest expense
-1.34M
-1.37M
-1.37M
-475.00K
Net interest expenses
-644.00K
-805.00K
-935.00K
-198.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.32M
-9.02M
-8.57M
10.99M
Gain or loss from assets sale
-
-
-
159.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps